The level of Alexithymia in alcohol-dependent patients does not influence outcomes after inpatient treatment

Hein A. de Haan, Arnt F.A. Schellekens, Jacobus Adrianus Maria van der Palen, Robbert-Jan Verkes, Jan K. Buitelaar, Cor A.J. de Jong

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)

Abstract

Background: The inability of individuals with Alcohol Use Disorders (AUD) to recognize and describe their feelings and cravings may be due to alexithymia. Previous researches have shown evidence for a negative influence of alexithymia on treatment outcomes in patients with AUD. Therefore, it was hypothesized that high alexithymic patients with AUD would benefit less from cognitive behavioral therapy (CBT) compared with low alexithymic patients. Methods: One hundred alcohol-dependent inpatients (DSM IV) were assessed with the Mini International Neuropsychiatric Interview for psychiatric disorders, the Toronto Alexithymia Scale (TAS-20), and the European Addiction Severity Index (EuropASI). Baseline alexithymia, as a categorical and continuous variable, was used to compare or relate baseline demographic and addiction characteristics, time in treatment, abstinence, and differences in addiction severity at 1-year follow-up. Analyses were performed using χ2 test, analysis of variance or Kruskal–Wallis, paired t-tests or Wilcoxon’s signed rank tests, multivariate logistic, and linear regression models, as appropriate. Results: The prevalence of high alexithymia (TAS-20 > 61) was 45%. The total TAS-20 score correlated negatively with years of education (r = −.21; p = .04) and positively with the psychiatry domain of the EuropASI (r = .23; p = .04). Alexithymia showed no relation to abstinence, time in treatment, or change in severity of alcohol-related problems on the EuropASI. Conclusion: High alexithymic patients with AUD do benefit equally from inpatient CBT-like treatment as low alexithymic patients with AUD. Scientific significance: Multimethod alexithymia assessments with an observer scale have been advised to judge the relationship with resulting outcome in CBT.
Original languageEnglish
Pages (from-to)299-304
JournalAmerican journal of drug and alcohol abuse
Volume38
Issue number4
DOIs
Publication statusPublished - 2012

Fingerprint

Affective Symptoms
Inpatients
Alcohols
Cognitive Therapy
Therapeutics
Psychiatry
Linear Models
Nonparametric Statistics
Diagnostic and Statistical Manual of Mental Disorders
Analysis of Variance
Emotions
Logistic Models
Demography
Interviews
Education
Research

Keywords

  • METIS-291508
  • IR-83865

Cite this

de Haan, Hein A. ; Schellekens, Arnt F.A. ; van der Palen, Jacobus Adrianus Maria ; Verkes, Robbert-Jan ; Buitelaar, Jan K. ; de Jong, Cor A.J. / The level of Alexithymia in alcohol-dependent patients does not influence outcomes after inpatient treatment. In: American journal of drug and alcohol abuse. 2012 ; Vol. 38, No. 4. pp. 299-304.
@article{7ca25eba233642b7a3d470ffbc20d5da,
title = "The level of Alexithymia in alcohol-dependent patients does not influence outcomes after inpatient treatment",
abstract = "Background: The inability of individuals with Alcohol Use Disorders (AUD) to recognize and describe their feelings and cravings may be due to alexithymia. Previous researches have shown evidence for a negative influence of alexithymia on treatment outcomes in patients with AUD. Therefore, it was hypothesized that high alexithymic patients with AUD would benefit less from cognitive behavioral therapy (CBT) compared with low alexithymic patients. Methods: One hundred alcohol-dependent inpatients (DSM IV) were assessed with the Mini International Neuropsychiatric Interview for psychiatric disorders, the Toronto Alexithymia Scale (TAS-20), and the European Addiction Severity Index (EuropASI). Baseline alexithymia, as a categorical and continuous variable, was used to compare or relate baseline demographic and addiction characteristics, time in treatment, abstinence, and differences in addiction severity at 1-year follow-up. Analyses were performed using χ2 test, analysis of variance or Kruskal–Wallis, paired t-tests or Wilcoxon’s signed rank tests, multivariate logistic, and linear regression models, as appropriate. Results: The prevalence of high alexithymia (TAS-20 > 61) was 45{\%}. The total TAS-20 score correlated negatively with years of education (r = −.21; p = .04) and positively with the psychiatry domain of the EuropASI (r = .23; p = .04). Alexithymia showed no relation to abstinence, time in treatment, or change in severity of alcohol-related problems on the EuropASI. Conclusion: High alexithymic patients with AUD do benefit equally from inpatient CBT-like treatment as low alexithymic patients with AUD. Scientific significance: Multimethod alexithymia assessments with an observer scale have been advised to judge the relationship with resulting outcome in CBT.",
keywords = "METIS-291508, IR-83865",
author = "{de Haan}, {Hein A.} and Schellekens, {Arnt F.A.} and {van der Palen}, {Jacobus Adrianus Maria} and Robbert-Jan Verkes and Buitelaar, {Jan K.} and {de Jong}, {Cor A.J.}",
year = "2012",
doi = "10.3109/00952990.2012.668597",
language = "English",
volume = "38",
pages = "299--304",
journal = "American journal of drug and alcohol abuse",
issn = "0095-2990",
publisher = "Informa Healthcare",
number = "4",

}

The level of Alexithymia in alcohol-dependent patients does not influence outcomes after inpatient treatment. / de Haan, Hein A.; Schellekens, Arnt F.A.; van der Palen, Jacobus Adrianus Maria; Verkes, Robbert-Jan; Buitelaar, Jan K.; de Jong, Cor A.J.

In: American journal of drug and alcohol abuse, Vol. 38, No. 4, 2012, p. 299-304.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - The level of Alexithymia in alcohol-dependent patients does not influence outcomes after inpatient treatment

AU - de Haan, Hein A.

AU - Schellekens, Arnt F.A.

AU - van der Palen, Jacobus Adrianus Maria

AU - Verkes, Robbert-Jan

AU - Buitelaar, Jan K.

AU - de Jong, Cor A.J.

PY - 2012

Y1 - 2012

N2 - Background: The inability of individuals with Alcohol Use Disorders (AUD) to recognize and describe their feelings and cravings may be due to alexithymia. Previous researches have shown evidence for a negative influence of alexithymia on treatment outcomes in patients with AUD. Therefore, it was hypothesized that high alexithymic patients with AUD would benefit less from cognitive behavioral therapy (CBT) compared with low alexithymic patients. Methods: One hundred alcohol-dependent inpatients (DSM IV) were assessed with the Mini International Neuropsychiatric Interview for psychiatric disorders, the Toronto Alexithymia Scale (TAS-20), and the European Addiction Severity Index (EuropASI). Baseline alexithymia, as a categorical and continuous variable, was used to compare or relate baseline demographic and addiction characteristics, time in treatment, abstinence, and differences in addiction severity at 1-year follow-up. Analyses were performed using χ2 test, analysis of variance or Kruskal–Wallis, paired t-tests or Wilcoxon’s signed rank tests, multivariate logistic, and linear regression models, as appropriate. Results: The prevalence of high alexithymia (TAS-20 > 61) was 45%. The total TAS-20 score correlated negatively with years of education (r = −.21; p = .04) and positively with the psychiatry domain of the EuropASI (r = .23; p = .04). Alexithymia showed no relation to abstinence, time in treatment, or change in severity of alcohol-related problems on the EuropASI. Conclusion: High alexithymic patients with AUD do benefit equally from inpatient CBT-like treatment as low alexithymic patients with AUD. Scientific significance: Multimethod alexithymia assessments with an observer scale have been advised to judge the relationship with resulting outcome in CBT.

AB - Background: The inability of individuals with Alcohol Use Disorders (AUD) to recognize and describe their feelings and cravings may be due to alexithymia. Previous researches have shown evidence for a negative influence of alexithymia on treatment outcomes in patients with AUD. Therefore, it was hypothesized that high alexithymic patients with AUD would benefit less from cognitive behavioral therapy (CBT) compared with low alexithymic patients. Methods: One hundred alcohol-dependent inpatients (DSM IV) were assessed with the Mini International Neuropsychiatric Interview for psychiatric disorders, the Toronto Alexithymia Scale (TAS-20), and the European Addiction Severity Index (EuropASI). Baseline alexithymia, as a categorical and continuous variable, was used to compare or relate baseline demographic and addiction characteristics, time in treatment, abstinence, and differences in addiction severity at 1-year follow-up. Analyses were performed using χ2 test, analysis of variance or Kruskal–Wallis, paired t-tests or Wilcoxon’s signed rank tests, multivariate logistic, and linear regression models, as appropriate. Results: The prevalence of high alexithymia (TAS-20 > 61) was 45%. The total TAS-20 score correlated negatively with years of education (r = −.21; p = .04) and positively with the psychiatry domain of the EuropASI (r = .23; p = .04). Alexithymia showed no relation to abstinence, time in treatment, or change in severity of alcohol-related problems on the EuropASI. Conclusion: High alexithymic patients with AUD do benefit equally from inpatient CBT-like treatment as low alexithymic patients with AUD. Scientific significance: Multimethod alexithymia assessments with an observer scale have been advised to judge the relationship with resulting outcome in CBT.

KW - METIS-291508

KW - IR-83865

U2 - 10.3109/00952990.2012.668597

DO - 10.3109/00952990.2012.668597

M3 - Article

VL - 38

SP - 299

EP - 304

JO - American journal of drug and alcohol abuse

JF - American journal of drug and alcohol abuse

SN - 0095-2990

IS - 4

ER -